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HPLC elution proﬁle and MALDI TOF MS analysis of electro-stimulated skin secretion of the Indian Ranid
frog Clinotarsus curtipes of the Western Ghats conﬁrmed the presence of multiple peptides. Peptides
eluted out of the C18 column at higher hydrophobic solvent region showed antibacterial activity against
diverse bacterial strains, including the clinical isolates of V. cholerae and methicillin resistant Staphylo-
coccus aureus (MRSA). Peptidomic analysis of the most potent chromatographic efﬂuent fraction iden-
tiﬁed ﬁve novel peptide amides having sequence homology with brevinin family. These peptides are
named as brevinin1CTcu1 (B1CTcu1) to brevinin1CTcu5 (B1CTcu5). Peptide B1CTcu1 is non-haemolytic
while the others are haemolytic in nature but all elicited potential antibacterial activity. B1CTcu5 is a
twenty-one residue peptide amide having proline hinge region in the middle and the typical C-terminal
intramolecular disulﬁde-bridged hepta peptide domain (Rana box) that is present in most of the brevinin
peptides. Analysis of their killing kinetics with E. coli and S. aureus and the ability to induce membrane
depolarization proved that these are two independent events. These novel multifunctional peptides play
an important role to protect C. curtipes from invading pathogenic microorganisms present in the
environment.
 2013 The Authors. Published by Elsevier Masson SAS. Open access under CC BY-NC-SA license.1. Introduction
Host defense peptides (HDPs) are endogenous antibiotics
secreted by the holocrine glands, play multifunctional role in the
innate immunity of vertebrates and other organisms [1]. These
effector molecules are rapidly produced ribosomally in response to
infections and defend the animal from invading pathogenic mi-
croorganisms. Majority of them are cationic in nature, vary in chain
length, possess amphipathic structure and exhibit broad-spectrum
antibacterial, antiviral, antifungal and anti-inﬂammatory activities
[2,3]. Their wide spread distribution in the animal and plant
kingdom suggest that they have served a fundamental role in the
evolution of complex multi-cellular organisms. Since majority of
these peptides target the microbial membrane, the chance to
develop resistance against them is negligible compared to con-
ventional antibiotics [4]. Therefore these molecules can serve as a: þ91 471 2348096.
.
r Masson SAS. Open access under CC BY-potential candidate to counter the menace of emerging multidrug
resistant strains of pathogenic microorganisms.
Extensive analysis of the frog skin and its secretion identiﬁed
several bioactive peptides that defend the animals from microbial
attack. The genus Rana is the most diverse and widely distributed
group of anuran amphibians, with more than 250 reported species
around world wide [5]. They posses many HDPs with broad spec-
trum antimicrobial activities like gaegurins [6] and rugosins [7] of
Rana rugosa, brevinins of Rana brevipodaporsa [8], Rana esculenta [9]
and Rana sphenocephala [10], esculentins of R. esculenta [11], rana-
lexin [12] and ranatuerins [13] of Rana catesbeiana, and temporins
[14] of Rana temporaria. Unfortunately this studywas limited only to
frog species of the temperate region and only a little is known about
the nature ofmolecules present in tropical frogs. TheWesternGhats
part, Kerala, India is one of the major biodiversity hotspot of the
world with high degree of endemism. A detailed exploration of the
defensive frog peptides of this region will help to understand their
amino acid assembly, secondary structure and valuable information
about their mode of action which may help to understand the
minimum structural requirement of a peptide to show antibacterial
activity. These molecules may also serve as a template to develop
novel anti-infectives with predicted bioactivities.
HDPs isolated from Ranid frogs have very high sequential sim-
ilarity and are grouped under Brevinin family [15]. These peptidesNC-SA license.
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segment and the C-terminal is a seven membered cyclic region
formed by a disulﬁde bond between i and i þ 6th cysteine residues.
The present study describes the isolation, characterization and
antibacterial activity of ﬁve novel skin secreted HDPs from the In-
dian ranid frog Clinotarsus curtipes. Structural analysis showed that
these peptides possess very high sequence homology with known
brevinin1 family peptides isolated from Ranidae frogs of Eurasian
and North American region. A detailed analysis of their primary and
secondary structure, biological activity and mechanism of action
will be useful to design and develop novel peptides based anti in-
fectives of known activity.
2. Materials and methods
2.1. Collection of frog skin secretions
Skin secretions were collected from twenty adult species of C.
curtipes (20e30 g; sex unknown) of the Western Ghats region in
Kerala, South India as previously described [16]. In brief, a mild
electric stimulation was given to the dorsal surface of the frog. The
skin secretion was collected by washing the frog skin with small
quantities of sterilized, deionized water acidiﬁed with triﬂuoro-
acetic acid. The frog was released in a healthy state back to ﬁeld
where it was collected. Skin secretions were pooled together,
frozen in liquid nitrogen, brought to the laboratory and lyophilized.
2.2. HPLC analysis of peptides
About 1mg of the lyophilized skin secretionwas dissolved in 1ml
of solvent A (waterwith 30% acetonitrile and 0.1% TFA), injected to C-
18 analytical column (Vydac 238 TP, 150  4.6 mm) and performed
the reverse phase high performance liquid chromatography (RP-
HPLC). Peptides were eluted out of the column by slowly increasing
the acetonitrile concentration upto 70% over a period of 88minwith
1ml/min ﬂow rate. Absorbance of the eluted solutionwasmonitored
at 214 and 280 nm. After analysing the HPLC proﬁle of the crude skin
secretion, the eluted solutions were collected as nine 10ml fractions.
After lyophilisation, the white powder obtained under each fraction
was dissolved in water and antibacterial nature was tested against
Escherichia coli by disc diffusion assay. The fraction eluted between
70 and 80 min that showed highest antibacterial activity was
collected and lyophilised. This potential fractionwas further puriﬁed
by RP-HPLC using the same program but starting with 40% aceto-
nitrile concentration in solvent A and the eluted fractions under each
peak was collected and lyophilized.
2.3. Sequence analysis
Aminoacidsequence ineachpeptidewasestablishedbyaminoacid
analysis, sequencing by automated Edman degradation (Shimadzu
CTO-10A) and mass ﬁngerprinting. Mass ﬁngerprint of the puriﬁed
sample after its reduction and tryptic digestion was carried out using
matrix-assisted laser desorption ionization time of ﬂight mass spec-
trometry (MALDI TOF/TOF). De novo sequencing was performed by
carrying out the peptide fragmentation by MS/MS 2 KV with CID ON
method using 4000 laser shots of intensity 4700. Frog protein uniprot
data basewas incorporated in Protein Pilot 2.0 and theMS/MS spectra
was searched against that data base for protein identiﬁcation. Primary
sequence was conﬁrmed by analysing all these results.
2.4. Peptide synthesis
C-terminal amidated peptides were synthesized by the stepwise
manual solid phase peptide synthesis (SPPS) technique usingCLEAR amide resin as the solid support and following the 9-
ﬂuorenylmethoxy carbonyl (Fmoc) chemistry [17]. After the syn-
thesis, peptide amide was cleaved from the resin by adding a
cleavage cocktail TFA/EDT/TIS/water (95:1.5:1.5:2 (v/v)) at room
temperature. After 4 h, the mixture was ﬁltered and the ﬁltrate was
concentrated under vacuum to 1/4th of its volume. The crude
peptide amide was precipitated by ice cold ether and collected by
centrifugation at 3000 rpm for 15 min. After lyophilisation it was
dissolved in solvent A and puriﬁed by injecting it into a C-18 col-
umn of RP-HPLC. The peptide amide was eluted out of the column
by slowly increasing the acetonitrile concentration to 70% in sol-
vent A over a period of 30min. Homogeneous puriﬁcation andmass
accuracy were conﬁrmed by analytical RP-HPLC proﬁle and MALDI
TOF MS analysis. The C-terminal disulphide bond formation in
B1CTcu5 was carried out by the oxidation of the two cysteine res-
idues in 50% aqueous DMSO in the absence of light. The extent of
cyclisation was monitored by injecting a small volume of the so-
lution to a C18 Vydac column at various time intervals and running
a gradient HPLC elution by increasing the acetonitrile concentration
in solvent A to 70% over a period of 20 min. The elution proﬁle
showed that more than 90% cyclisation was completed within 8 h.
B1CTcu5 having C-terminal rana box was recovered by repeating
the above puriﬁcation protocol.
2.5. Antimicrobial activity and killing kinetics
Bacterial strains used for in vitro antibacterial assay were E. coli
(MG1655), clinical isolates of Vibrio cholerae collected from Thir-
uvananthapuram medical college, Kerala, India, Staphylococcus
aureus (MTCC 9542), Bacillus subtillis (ATCC 14416), Bacillus coag-
ulans (ATCC 7050), Methicillin resistant S. aureus (ATCC 43300) and
Vancomycin resistant enterococcus (ATCC 29212). Bacterial cultures
were grown in Luria bertani broth (Hi-media) by overnight incu-
bation at 37 C with constant shaking. Microbial cultures having
106 CFU/ml were made from OD 0.6 culture. 1 mg/ml stock con-
centration of peptides were prepared in autoclaved double
distilled water and diluted in LB broth to make concentrations
ranging from 1 to 200 mg/ml. 50 ml bacterial culture was treated
with 50 ml of individual peptide amide solution of various con-
centrations and incubated for 24 h at 37 C with constant shaking
in a 96 well microtitre plate. Growth control wells had the same
amount of bacterial inoculum but without peptide. Absorbance at
600 nm was noted in every 3 h upto 24 h to assess the cell growth
and a graph was plotted with time against OD values. The mini-
mum inhibitory concentration (MIC) was taken as the dose at
which 100% growth inhibition was observed and it was calculated
from the graph.
The killing kinetic analysis of the peptides against Gram-
negative E. coli (MG1655) and Gram-positive S. aureus (MTCC
9542) were carried out at its sub MIC concentrations. Cells in mid-
logarithmic growth phase (OD600¼ 0.6) was diluted to get 106 CFU/
ml and incubated with the peptides at different time intervals 5, 30,
60, 90 and 120 min. Aliquots drawn at these time points were
plated on LB agar. The colony number was counted after incubating
the plates at 37 C for 24 h. Cells without treatment with the
peptides at the same time intervals as mentioned abovewere taken
as the positive control.
2.6. Haemolytic assay
Haemolytic assay was carried out by following the previously
described method [18]. In brief, 10 mg of the peptide was incubated
at 37 C for 30 min with 10% (v/v) fresh suspension of rabbit
erythrocytes in phosphate buffered saline (pH 7.2). The cells were
centrifuged (3000  g for 5 min), and absorbance of the
Fig. 1. RP-HPLC chromatogram of the skin secretion of C. curtipes. The acetonitrile
concentration in solvent A was increased to 70% over 88 min at a ﬂow rate of 1 ml/min.
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Triton X-100 was taken as positive control. Percentage haemolysis
was calculated by measuring the amount of haemoglobin released
due to erythrocytes lysis.
2.7. Circular dichroism spectroscopy
The secondary structure of the peptide was determined using a
Jasco J-715 spectropolarimeter. Respective peptides (200 mg) taken
in three differentmedium, triﬂuoro ethanol (TFE)ewater (30%, v/v),
5 mM TriseHCl (pH 7.8) and small unilamellar vesicles (SUV)
composed of 2-oleoyl-1-palmitoyl-sn-glycero-3-Phosphocholine
(POPC), 1-palmitoyl-20-oleoyl-sn-glycero-3-phosphoglycerol
(POPG) and an equimolar mixture of POPC and POPG (50:50). Each
of these solutions were taken in a quartz cell of 1 mm path length,
scanned from 190 to 250 nm at 25 C with bandwidth of 1 nmwith
scanning speed of 50 nm/min. The spectrum obtainedwas averaged
over three consecutive scans and the solvent CD signal was sub-
tracted. Percentage helicity was calculated from the mean residue
ellipticity at 222 nm in CD spectra. The average mean residue
ellipticity ([q]/1000 [degree square centimeters/decimole]) was
plotted against wavelength (nm). After CD measurement the con-
centration of each peptide in the sample solution was reconﬁrmed.
2.8. Flow cytometry
E. coli (MG1655) and S. aureus (MTCC9542) cells were incubated
with peptides at their respective MICs for 1 h at 37 C and the
membrane potential sensitive dye bis-(1,3-dibutylbarbituric acid)
triethynyl oxonol [DiBAC4 (3)] (1 mg/ml) was added to it. After 10min
incubation, the cell suspension was centrifuged (5000  g) for 8 min
and the pellets obtained were suspended in 500 ml PBS. Peptide
induced bacterial membrane depolarization was measured ﬂow
cytometrically using argon laser with an excitation wavelength at
490 nm and the emission maximum at 516 nm [19]. The green ﬂuo-
rescence in the channel FL1 was measured. A total of 10,000e50,000
events were analysed in each sample. The data acquisition and
analysis was carried out using DIVA software (BD). The Forward
Scatter Side ScattereDot Plot referring to relative cell size, granularity
of bacterial population was differentiated from the background sig-
nals andgated for evaluationof theﬂuorescence. Amarkerwasdrawn
togate theviable cells in the control. Theantimicrobial activitiesof the
peptides were correlated with its membrane potential effect which
was measured as the percentage of the depolarized bacteria.
3. Results
3.1. Puriﬁcation of antimicrobial peptides
The C18 analytical HPLC proﬁle of electrically stimulated skin
secretion of the Indian bicoloured frog C. curtipes showed the
presence of several peaks (Fig. 1). Mass analysis proved that each
peptide eluted out of the column had different masses. The entire
chromatographic efﬂuent was collected in nine different equal
fractions. After lyophilisation aqueous solutions of the individual
fractions were tested for antibacterial activity by disc diffusion
assay. The 8th fraction collected between 70 and 80 min after the
injection showed maximum potency to destroy the bacterial cells.
This fraction was further puriﬁed by RP-HPLC and the eluted frac-
tions under each peak collected were lyophilised.
3.2. Sequence characterisation
Mass analysis of the eluted fractions under each peak in the
chromatogram conﬁrmed that each peptide was different. Theiramino acid sequence was determined by mass ﬁngerprinting and
amino acid sequencing. The results showed that all the ﬁve pep-
tides were different and named in accordance with the recent
nomenclature system as Brevinin1CTcu1 to Brevinin1CTcu 5
(B1CTcu1eB1CTcu5) [20]. The ﬁrst peak of the 8th fraction in the
chromatogram was represented by a 19-residue peptide amide
B1CTcu1. The second and third peaks belonged to a 23-residue
peptide amide B1CTcu2 and a 22-residue peptide amide B1CTcu3.
The fourth peak was represented by a 23-residue peptide amide
B1CTcu4 and the ﬁfth peak was represented by a 21-residue pep-
tide amide having a C-terminal cyclic hepta domain. The amino acid
sequences are given in Table 1.
3.3. Secondary structure analysis
The CD spectroscopy based secondary structural analysis
showed that these peptides have a high propensity to adopt the
alpha helical conformation in membrane mimetic environment
like TFE in water (Fig. 2A). B1CTcu2e5 attained a well deﬁned
alpha helical structure in anionic and bacterial membrane
mimicking lipid environments (POPG and POPC/POPG) as indi-
cated by a negative ellipticity and a double minima at 208 and
222 nm. But B1CTcu1 showed only a very low propensity to adopt
alpha helical structure in POPC/POPG. In zwitterionic POPC me-
dium all the peptides exhibited only a very low tendency to form
an alpha helix and had no preferred conformation in 5 mM Trise
HCl. The ratio of molar ellipticities at 222 and 208 nm can be used
to study the presence of coiled-coil helical conformation in a
peptide. A value below one indicates the presence of non-
interacting helices and above one indicates the probability of
interaction between the two stranded coiled-coil peptides. Their
molar ellipticity ratio at 222 nm and 208 nm (q222/q208) in TFEe
water for B1CTcu1 (0.657), B1CTcu2 (0.769), B1CTcu3 (0.692) and
B1CTcu4 (0.903) predicted that these peptides exist as non-
interacting helices.
3.4. Antimicrobial activity and killing kinetics
Antibacterial activity analysis conﬁrmed that these peptides are
potent antimicrobial agents that can kill a broad range of bacteria
with MICs ranging from 6.25 to 100 mg/ml (Table 2). But their
Table 1
Structural parameters of the peptides calculated by Protparam tool.
Peptide No of residue Peptide sequence GRAVY Net charge Calculated Observed
B1CTcu1 19 LIAGLAANFLPKLFCKITK 1.042 3 2061.6 2061.56
B1CTcu2 23 FLPLLAGLAANFLPKIFCKITRK 0.883 4 2575.2 2573.7
B1CTcu3 22 LPLLAGLAANFLPKIFCKITRK 0.795 4 2428 2426.664
B1CTcu4 23 FLPFIAGMAAKFLPKIFCAISKK 1.039 4 2542.2 2540.663
B1CTcu5 21 LIAGLAANFLPQILCKIARKC 1.067 3 2256.8 2255.5
GRAVY: grand average of hydrophobicity, calculated as the sum of hydropathy values of all the amino acids, divided by the number of residues in the sequence.
P. Abraham et al. / Biochimie 97 (2014) 144e151 147potency was different against different bacterial strains. Killing
kinetic analysis can provide the rate at which a peptide kill bacteria
over time and indicates whether the antibacterial agent possess
bacteriostatic or bactericidal activity. Killing kinetic study against
E. coli and S. aureus showed that these peptides initiated their ac-
tion immediately after addition and the 50% reduction in bacterial
count takes place in a short period. But for the complete bacterial
elimination the required time was found to be 60e90 min B1CTcu3
killed the entire S. aureus in about 5 min and the entire E. coli in
about 15 min (Fig. 3). The results showed that S. aureus was highly
susceptible to B1CTcu1eB1CTcu4 compared to B1CTcu5. The im-
mediate drop in CFUs is a reﬂection of the bactericidal nature of
these frog derived peptides.Fig. 2. A. CD spectra of peptides in 30% triﬂuro ethanolewater system. B. CD spectra in SU
composed of 50:50 POPC/POPG.3.5. Haemolytic activity
B1CTcu1 displayed a preferential selectivity towards the pro-
karyotic cell membrane compared to that against eukaryotes.
B1CTcu2eB1CTcu5 showed high haemolytic activity against rabbit
RBCs even at 10 mg/mL concentration. Their haemolytic potential
increased with increase in peptide concentration (Table 2).
3.6. Flow cytometry
Flow cytometric analysis using a membrane potential sensitive
dye [DiBAC4 (3)] revealed that these peptides are not capable of
inducing any cytoplasmic membrane depolarization (data notV composed of POPC. C. CD spectra in SUV composed of POPG. D. CD spectra in SUV
Table 2
Antibacterial and haemolytic activity of peptides.
MIC (mg/ml)a
B1CTcu1 B1CTcu2 B1CTcu3 B1CTcu4 B1CTcu5
Gram positive
Staphylococcus aureus
MTCC 9542
12.5 12.5 6.25 25 ND
Bacillus subtilis
MTCC 14416
>25 12.5 12.5 25 >200
Bacillus coagulans
ATCC 7050
6.25 6.25 6.25 ND 6.25
VRE ATCC 29212 ND 50 100 25 ND
MRSA ATCC 43300 ND 50 50 <6.25 ND
Gram negative
E. coli MG1655 10 10 6.25 20 7
Vibrio cholerae (IS) 12.5 12.5 12.5 25 15
% Haemolysis 1 17.8 45 54.8 37.5
MIC:Minimum inhibitory concentration.These concentrations represent the mini-
mum dose required to kill the entire microorganisms.ND:no detectable activity
tested upto 200 mg/ml.IS is clinically isolated strain.
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B1CTcu4 at their respective MICs could not induce complete
membrane depolarization (Fig. 4) in E. coli even after 3 h of incu-
bation. Though the peptides (B1CTcu1e4) completely eliminated
the S. aureus in 30 min, ﬂow cytometric analysis showed that they
need at least 3 h to cause membrane destabilising effect at their
respective MIC. B1CTcu5 which was not effective against S. aureus
was found to be effective against Bacillus coagulans. But V. cholerae
(IS) did not showed any shift in their population.
4. Discussion
The inexorable on-going emergence of new strains of microor-
ganisms with acquired resistance to currently known antibiotics
triggered an alarming threat to public health. Conventional anti-
biotics are increasingly ineffective and become victim of their own
success. MRSA is one of the best known examples which killFig. 3. Kinetics of killing of bacteria .AeB, S. aureus, CeD, E. coli. Cells in the mid-logarithmic
of peptides (A and C, 3.25 mg/ml, B and D, 6.5 mg/ml) at 37 C, aliquots were drawn out at diffe
were counted after incubating the plates at 37 C for 24 h.thousands of people every year. This stimulated the world wide
search for novel therapeutic agents that can eradicate such disease
causing microorganisms [21]. In nature, the evolutionary success of
multicellular organisms is largely due to the development of very
diverse and elaborate defense systems, collectively known as host
immunity. The granular glands of the amphibians secrete peptides
having broad spectrum antimicrobial activity which defend the
animal against any kind of stress or predator attack [22]. Despite
having a huge reservoir of amphibian diversity in Western Ghats,
very little is known about the kind of peptides that protect the
frogs. The genus Rana, the most diverse and world widely distrib-
uted group of anuran amphibians is known as a rich source of HDPs.
This prompted us to investigate the peptide repertoire in C. curtipes,
a bicoloured frog found in forests areas of Western Ghats mountain
range in India [23].
Analysis of electrically stimulated skin secretion of C. curtipes
identiﬁed the presence of multiple peptide amides. Since the
characterisation of entire eluted peptide is a time consuming and
costly affair, this studywas conﬁned to the 8th fraction eluted out of
the column which showed highest antibacterial activity against
E. coli (MG1655). Peptidomic analysis of this fraction identiﬁed the
presence of ﬁve novel peptides. Though naming themwith respect
to a previously described family is an arbitrary process, sequence
homology analysis of the new peptides helped to group them under
brevinin family with assigned names B1CTcu1eB1CTcu5. These
peptides showed variations in their amino acid sequence and chain
length compared to that isolated from ranid frogs of temperate
zones. The environmental stress, bacterial diversity, climatic con-
ditions and frog population might have played a signiﬁcant role in
bringing these changes.
B1CTcu1eB1CTcu4 are linear because their primary sequence
contain only one cysteine residue. B1CTcu1 may be considered as a
very unique member among the ﬁve peptides because it had very
low sequence homology with the known brevinin family members.
But due to its comparatively higher homology with brevinins
compared to other family members it was included in the same
family. The only difference between B1CTcu2 and B1CTcu3 is thephase of growth (105 colony forming units) were incubated with different concentration
rent time intervals and plated onto a LB agar plate. The number of colony forming units
Fig. 4. Flow cytometry analysis of peptide B1CTcu1eB1CTcu5 induced membrane depolarization. (A) Untreated E. coli (MG1655) cells; (BeF) B1CTcu1eB1CTcu5 treated E. coli cells;
(G) gramicidin treated E. coli cells; (H) untreated S. aureus (MTCC 9542), (IeM) B1CTcu1eB1CTcu5 treated S. aureus (N) indolicidin treated S. aureus. 106 CFU/ml microbial cells were
treated with peptides at its MIC for 1 h and treated with 1 mg/ml of [DiBAC4 (3)]. Membrane depolarization is indicated by a shift in the population.
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blast analysis revealed that these two peptides possess very high
sequence similarity with brevinin 1E, isolated from R. esculenta [11].
Similarly B1CTcu4 showed very high sequence similarity with
Brevinin1Ba reported from North American frog Rana berlandieri
[24]. B1CTcu5 has a hydrophobic N-terminal region, proline hinged
middle region and a positively charged C-terminal seven member
cyclic peptide domain (CyseLyseXaa4eCys) formed by an intra-
disulphide bridge. HPLC elution proﬁle analysis showed that hy-
drophobic character of the folded B1CTcu5 was slightly higher than
that of its linear counterpart.
These peptides showed a higher propensity to adopt an a-helical
conformation in membrane mimicking solvents and a comparative
study of their molar ellipticity ratio at 222 nm and 208 nm (q222/
q208) predicted that all peptides existed as non-interacting helices
in solution [18]. Secondary structure analysis using model bacterial
membrane revealed that except B1CTcu1 all other peptides had the
ability to bind the bacterial membrane and assume an alpha helical
conformation upon binding. The antibacterial peptide B1CTcu1
showed only very low propensity to acquire alpha helical confor-
mation in membrane mimicking environment. The mode of action
of this peptide may be different from the rest and required a
thorough investigation to ﬁnd out the exact mechanistic details.
Even though B1CTcu1eB1CTcu3 showed higher antibacterial
activity against both Gram positive and negative strains
compared to B1CTcu4 and B1CTcu5 only B1CTcu1 can be
considered as a potential template to develop anti-infective
agents because of its broad spectrum antibacterial activity and
nonhaemolytic nature. Removal of N-terminus phenylalanine
residue from B1CTcu2 that resulted B1CTcu3, helped to increase
the overall hydrophilic character of the peptide which was
conﬁrmed by the analytical HPLC elution proﬁle. Though this
deletion slightly enhanced in the antibacterial nature of the
peptide its haemolytic potential also was increased about 2.5 fold
excess. The highly haemolytic B1CTcu4 can effectively arrest the
multiplication of drug resistant superbug MRSA for unknown
reasons. The killing kinetic experiment substantiated the bacte-
ricidal nature of all these peptides.
Cytoplasmic membrane depolarization induced by a peptide is
considered as one of the major events that could lead to bacterial
cell death after its electrostatic interaction with the bacterial
membrane. The extent of disruption of cytoplasmic membrane
permeability can be quantiﬁed using a membrane potential sensi-
tive dye [DiBAC4 (3)] which can help to discriminate ﬂow cyto-
metrically the intact non-ﬂuorescent and depolarised ﬂuorescent
bacteria. The negatively charged oxonol dyes undergo a membrane
potential dependent distribution between the cytoplasm and the
extra cellular medium. This voltage sensitive dye enters the depo-
larised cells and binds to lipid rich intracellular components.
Therefore, those cells having a membrane potential exclude oxonol
and produce only weak ﬂuorescence. When the cell loses the
membrane potential, the dye will enter the cell and enhance the
ﬂuorescence [25]. Analysis showed that B1CTcu1, B1CTcu2 and
B1CTcu4 have high antibacterial activity but are not able to induce
complete membrane depolarization in E. coli cells at their respec-
tive MIC even after 3 h of incubation. Though these peptides can kill
S. aureus at their MICs within a short period, the peptide induced
cytoplasmic membrane depolarization required very long time.
During the ﬁrst hour of incubation there is no visible cytoplasmic
membrane depolarization (data not shown). These results proved
that the cytoplasmic membrane depolarization and bacterial cell
death are two independent events as demonstrated by Friedrich
et al. [26]. The process of membrane depolarization cannot always
lead to bacterial killing and it could be one of the several events or
an additional effect presumably after cell death.Structure activity studies using synthetic analogues of B1CTcu4
which is effective against MRSA could help to understand the
importance of sequential arrangement of amino acid, secondary
structure and their inﬂuence in bacterial membrane disruption.
This knowledge may eventually help to design and synthesis of
novel non-haemolytic peptides with potent anti-MRSA activity.
Similarly B1CTcu5 having the C-terminal ran box showed some
preferential activity towards the gram negative strains compared to
gram positive strains. To understand the exact of mechanism that
conferred preferential activity to this peptide also required the
synthesis of many analogues and their bioactivity studies.
The present study identiﬁed ﬁve novel brevinin family anti-
bacterial peptides secreted by a bicoloured frog C. curtipes endemic
to Western Ghats, Kerala. The ﬁrst four peptides are acyclic unlike
most of the reported brevinin family members. The haemolytic
B1CTcu4 has the ability to kill MRSA speciﬁcally while the non-
haemolytic B1CTcu1 showed activity against broad spectrum of
bacteria. B1CTcu1 may be used as a template to design analogues to
understand their structure activity relationship and then to
develop novel anti-infectives against pathogenic bacteria including
drug resistant super bugs. These peptides can also be used as
taxonomic and phylogenetic marker to study the evolutionary
relationship between ranid frogs.Acknowledgements
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